U.S. Federal Trade Commission (FTC)

Phase One Announces Patent for Locking Hemodialysis Catheter

HINGHAM, Mass.—Phase One Medical LLC recently announced the issuance of the first in a family of patents for closing the distal end of a hemodialysis catheter. ...More
September 29, 2011
Posted in News, Business
DaVita Divests 30 Clinics to Close DSI Renal Acquisition

DENVER—DaVita Inc. said Sept. 6 that it will divest 30 clinics for $91 million in order to comply with federal regulators in closing its acquisition of DSI Renal. ...More
September 6, 2011
Posted in News, Business
DaVita Gains Fresenius' 2006 Divestitures (Sort of)

The world of business acquisitions can often be a mix of tangled histories and ironies, and it seems DaVita’s $690 million acquisition of DSI Renal is no different. ...More
February 4, 2011
Posted in Blog, Business
Report: Exclusivity Period on Biotech Drugs Too Long

A Federal Trade Commission (FTC) report released June 11 said generic versions of expensive biotechnology drugs would reduce the amount of money spent on healthcare in the United States; however, brand-name manufacturers push for "the 12- to 14-year regulatory exclusivity ...More
June 16, 2009
Posted in News, Business, Clinical & Pharma, Government & Regulation